Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies . J. Can. Res. Updates. 2018;7(3):75-78. doi:10.6000/1929-2279.2018.07.03.2